Cargando…
Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Médica Brasileira
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/ https://www.ncbi.nlm.nih.gov/pubmed/37585983 http://dx.doi.org/10.1590/1806-9282.20230090 |
_version_ | 1785090179954900992 |
---|---|
author | Varshney, Amit Rawat, Ramakant |
author_facet | Varshney, Amit Rawat, Ramakant |
author_sort | Varshney, Amit |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10427181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Associação Médica Brasileira |
record_format | MEDLINE/PubMed |
spelling | pubmed-104271812023-08-16 Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India Varshney, Amit Rawat, Ramakant Rev Assoc Med Bras (1992) Review Article Associação Médica Brasileira 2023-08-14 /pmc/articles/PMC10427181/ /pubmed/37585983 http://dx.doi.org/10.1590/1806-9282.20230090 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Varshney, Amit Rawat, Ramakant Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title | Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title_full | Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title_fullStr | Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title_full_unstemmed | Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title_short | Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India |
title_sort | comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in india |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/ https://www.ncbi.nlm.nih.gov/pubmed/37585983 http://dx.doi.org/10.1590/1806-9282.20230090 |
work_keys_str_mv | AT varshneyamit comparisonofsafetyandefficacyofdapagliflozinandempagliflozinintype2diabetesmellituspatientsinindia AT rawatramakant comparisonofsafetyandefficacyofdapagliflozinandempagliflozinintype2diabetesmellituspatientsinindia |